Nullomer derived anticancer peptides (NulloPs): Differential lethal effects on normal and cancer cells in vitro

► First use of the nullomer (absent sequences) approach to drug development. ► NulloP 9S1R causes mitochondrial impairment, and ultimately cell death. ► NulloPs effects increase on cancer cells over time, and decrease on normal cells.